Biotech

All Articles

Navigator raises $100M to create brand new autoimmune pipeline

.Navigator Medicines has actually outfitted on its own along with $100 million in set A funds as the...

Duality looks for money for ADC tests as IPO wave spreads to Asia

.China's Duality Biotherapeutics has actually submitted (PDF) documentation for a Hong Kong IPO, loo...

YolTech offers China legal rights to gene modifying treatment for $29M

.4 months after Mandarin gene editing company YolTech Therapeutics took its own cholesterol levels d...

Addex supply rises after Indivior provides to $300M for substance

.Indivior is actually picking up a tiny molecule allosteric modulator created to treat material usag...

Molecular Allies adjusts AML trial over 'suboptimal direct exposure'

.Molecular Companions has identified "suboptimal exposure" to its tetra-specific T-cell engager as t...

Despite mixed market, an equity capital resurgence can be being available in Europe: PitchBook

.While the biotech financial investment scene in Europe has slowed relatively complying with a COVID...

8 months after a $213M fundraise, gene editor Volume makes decreases

.After raising $213 million in 2023-- among the year's most extensive personal biotech rounds-- Tome...

BioMarin constructs exec group along with biotech vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial management hirings, firings an...

Biopharma Q2 VC reached highest degree considering that '22, while M&ampA reduced

.Equity capital backing into biopharma cheered $9.2 billion all over 215 sell the second quarter of ...

Bicara, Zenas look for IPOs to push late-phase resources toward market

.Bicara Therapies and also Zenas Biopharma have provided fresh motivation to the IPO market along wi...